FDA
approval
· 2018-11-21
FDA Approved: DAURISMO — Original Application (Pfizer Laboratories Div Pfizer Inc)
Summary
FDA approved DAURISMO (glasdegib) from Pfizer as an original NDA for the treatment of adults with acute myeloid leukemia who are not candidates for intensive ch…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DAURISMO (GLASDEGIB)